Boc-L-beta-HTyr(Bzl)-OH

Boc-L-beta-HTyr(Bzl)-OH is a protected tyrosine derivative featuring an N-terminal Boc (tert-butoxycarbonyl) group and a benzyl-protected phenolic side chain (O-benzyl), with the β-hydroxylated tyrosine side-chain architecture preserved for downstream functionalization. This amino acid building block is commonly used in peptide synthesis workflows where orthogonal protection and controlled reactivity are required during coupling, segment assembly, and purification. The combination of Boc and O-benzyl protection supports reliable handling under standard peptide chemistry conditions while protecting the phenol from undesired side reactions.

1. Solid-Phase Peptide Synthesis

Boc-L-beta-HTyr(Bzl)-OH is used by peptide synthesis groups to incorporate a β-hydroxylated tyrosine residue into protected peptide sequences, particularly when phenolic side-chain protection is needed to prevent side reactions during chain elongation. The Boc-protected amino terminus enables compatibility with established peptide assembly strategies where N-deprotection precedes coupling, while the O-benzyl group helps maintain side-chain integrity through multiple coupling and wash cycles. This makes the reagent a practical choice for custom peptide manufacturing research, including the preparation of peptide segments that later require controlled deprotection to reveal the native phenolic functionality.

2. Modified Peptide Segment Assembly

Boc-L-beta-beta-HTyr(Bzl)-OH supports the synthesis of modified peptide segments used in structure-function studies, where the β-hydroxylated tyrosine motif and protected phenol are introduced as a defined building block. Research teams developing peptide libraries or conducting SAR-style investigations often rely on such protected amino acid derivatives to standardize side-chain chemistry across analogs and to minimize variability introduced by incomplete protection. By maintaining orthogonal protection between the N-terminus and the phenolic oxygen, the building block fits workflows that require sequential assembly of protected intermediates followed by later side-chain unveiling for downstream biological or biophysical evaluation.

3. Pharmaceutical Intermediate Development

Boc-L-beta-HTyr(Bzl)-OH is frequently selected as a pharmaceutical intermediate building block for the preparation of protected tyrosine-containing fragments used in medicinal chemistry programs. Synthetic chemists use this type of amino acid derivative to manage chemoselectivity when constructing larger, functionalized scaffolds that include tyrosine-derived motifs while keeping the phenolic group masked during intermediate formation and purification. The Boc and O-benzyl protection pattern supports stepwise downstream transformations, enabling controlled conversion of protected intermediates into more reactive or deprotected forms at later stages of development.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors